Search

Landera, Mario A

P291

DOES THE MODE OF PROPHYLACTIC SWALLOWING THERAPY DELIVERY INFLUENCE SWALLOWING OUTCOMES IN PATIENTS UNDERGOING DEFINITIVE CHEMORADIATION FOR HEAD AND NECK CANCER?

Functional Outcomes / Quality

Donna S Lundy, PhD, BCSS, FASHA; Mario A Landera, SLP, D; Zoukaa Sargi, MD; Donald Weed, MD; Michael Samuels, MD; Amanda Demane, MA; Cesar Perez, MD; Deukwoo Kwon, PhD

U of Miami